Please join the CIBRN Leaders on Tuesday, October 24th at 8:00 pm EST for a one hour, in-depth, cross-discipline discussion of CIBRN 2017 Question #4, Question #5, Question #6 and Question #7 surrounding surrounding the implications of the evolving biosimilar landscape on clinical practice and patient health in Canada.
This webinar is intended for the ALL CIBRN members.
Webinar connection details have been sent to you by email. If you have any questions about the webinar or how to connect, please contact email@example.com.
Prior to the webinar, you are invited to visit the CIBRN community on Sosido to review the questions & responses and to reply with your personal clinical perspectives